Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

The document concludes that there are various treatments for diseases linked to scarring hair loss, especially for primary scarring alopecia.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Some breast cancer chemotherapy can cause permanent hair loss.

Alopecia areata might help slow down certain cancers.

Cetuximab can cause unusual hair growth and hair loss.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Early treatment is important for better hair regrowth in elderly women with hair loss.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Fullerene C60 shows promise as a new treatment for various skin conditions.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Minoxidil can reduce functions related to androgen receptors.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.